Guihua Zhong

机构：Zhejiang Chinese Medical University, Southern Medical University

发表论文 16 篇 · 总被引 226 次 · h-index 7

代表论文

• Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial (2022 · Journal of Experimental & Clinical Cancer Research · 被引 75)
• Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma (2022 · Frontiers in Immunology · 被引 36)
• Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis (2022 · Frontiers in Oncology · 被引 30)
• Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe (2021 · Cancer Cell International · 被引 29)
• How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19? (2020 · Radiotherapy and Oncology · 被引 27)
• Clinical Characteristics and Prognosis of Small Cell Carcinoma in the Nasopharynx: A Population-Based Study (2022 · Cancer Control · 被引 9)